📰 Jane Wasman News
Jane Wasman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jane Wasman. Real-time updates on events, politics, business and more.
October 3, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual Meeting of Stockholders. Current Director Jane Wasman, JD, has been ap...
October 2, 2023
Athersys, Inc. , a regenerative medicine company developing MultiStem® for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual...
June 25, 2022
A look at the most prominent Northeast Ohio business stories of the past week.
June 21, 2022
The Cleveland-based regenerative medicine company, which is undertaking cost-cutting and restructuring efforts, cut the size of the board of directors in half ahead of the annual meeting of shareholders. That meeting will take place on Thursday, July 28.
June 21, 2022
Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures - read this article along with other careers information, tips and advice on BioSpace